CoChat
Sign Up
Cited by 12

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Epigenetic modification in gliomas: role of the histone methyltransferase EZH2

Bian, Er-Bao, Li, Jia, He, Xiao-Jun, Zong, Gang, Jiang, Tao, Li, Jun, Zhao, Bing·2014·Expert Opinion on Therapeutic Targets
DOI 10.1517/14728222.2014.941807
Open this paper in CoChat — free account

Abstract

Introduction Gliomas are characterized by increased anaplasia, malignization, proliferation and invasion. They exhibit high resistance to standard treatment with combinations of radiotherapy and chemotherapy. They are currently the most common primary malignancy tumors in the brain that is related to a high mortality rate. Recently, increasing evidence suggests that EZH2 is involved in a number of glioma cell processes, including proliferation, apoptosis, invasion and angiogenesis. Areas covered In this review, we emphasize the role of EZH2 in gliomas. We also address that EZH2 interacting with DNA methylation mediates transcriptional repression of specific genes in gliomas, and the regulation of EZH2 by microRNAs in gliomas. Expert opinion Although the exact role of EZH2 in gliomas has not been fully elucidated, to understand the role of EZH2 proteins in epigenetic modification will provide valuable insights into the causes of gliomas, and pave the way to the potential future applications of EZH2 in the treatment of gliomas.

Overview

Integrity signals

Registry

Crossref · 10.1517/14728222.2014.941807

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 2 references

Research works printed but not linked: 94

  1. Hamza MA, 2014, Curr Oncol Rep, 16, 379, 10.1007/s11912-014-0379-z · DOI
  2. 10.1146/annurev.pathol.1.110304.100043 · DOI
  3. 10.1007/s00401-007-0243-4 · DOI
  4. 10.2353/ajpath.2010.100680 · DOI
  5. Gupta K, 2012, J Cancer Res Clin Oncol, 138, 1971, 10.1007/s00432-012-1323-y · DOI
  6. 10.1309/6JNX4PA60TQ5U5VG · DOI
  7. Perry A, 2003, Neuro Oncol, 5, 168, 10.1215/S1152851702000443 · DOI
  8. 10.1097/00130404-200303000-00003 · DOI
  9. Dolecek TA, 2012, Neuro Oncol, 14, v1, 10.1093/neuonc/nos218 · DOI · Paper page
  10. 10.1200/JCO.2011.38.4818 · DOI
  11. Smith JS, 2008, J Clin Oncol, 26, 1338, 10.1200/JCO.2007.13.9337 · DOI · Paper page
  12. 10.1016/S0140-6736(05)67070-5 · DOI · Paper page
  13. Weller M, 2012, Cancer J, 18, 40, 10.1097/PPO.0b013e318243f6c9 · DOI
  14. Hadjipanayis CG, 2009, J Mol Med (Berl), 87, 363, 10.1007/s00109-009-0440-9 · DOI
  15. 10.1016/j.bcp.2010.04.035 · DOI
  16. 10.1016/S1470-2045(11)70257-1 · DOI
  17. 10.1038/nrc2499 · DOI
  18. Natsume A, 2013, Cancer Res, 73, 4559, 10.1158/0008-5472.CAN-13-0109 · DOI
  19. Vescovi AL, 2006, Nat Rev Cancer, 6, 425, 10.1038/nrc1889 · DOI
  20. Cardoso C, 2000, Eur J Hum Genet, 8, 174, 10.1038/sj.ejhg.5200439 · DOI
  21. 10.1038/nature09784 · DOI · Paper page
  22. 10.1126/science.1076997 · DOI · Paper page
  23. 10.1101/gad.1035902 · DOI · Paper page
  24. Muller J, 2002, Cell, 111, 197, 10.1016/S0092-8674(02)00976-5 · DOI
  25. Lachner M, 2001, Nature, 410, 116, 10.1038/35065132 · DOI · Paper page
  26. Sauvageau M, 2010, Cell Stem Cell, 7, 299, 10.1016/j.stem.2010.08.002 · DOI · Paper page
  27. Wang H, 2004, Nature, 431, 873, 10.1038/nature02985 · DOI
  28. 10.1158/1078-0432.CCR-10-2156 · DOI
  29. 10.1073/pnas.1116418109 · DOI
  30. 10.1038/ng.518 · DOI
  31. 10.1038/ng.892 · DOI
  32. Wigle TJ, 2011, FEBS Lett, 585, 3011, 10.1016/j.febslet.2011.08.018 · DOI
  33. 10.1182/blood-2010-11-321208 · DOI
  34. Arisan S, 2005, Urol Int, 75, 252, 10.1159/000087804 · DOI
  35. 10.1073/pnas.1933744100 · DOI · Paper page
  36. Matsukawa Y, 2006, Cancer Sci, 97, 484, 10.1111/j.1349-7006.2006.00203.x · DOI
  37. Raman JD, 2005, Clin Cancer Res, 11, 8570, 10.1158/1078-0432.CCR-05-1047 · DOI
  38. Sudo T, 2005, Br J Cancer, 92, 1754, 10.1038/sj.bjc.6602531 · DOI
  39. 10.1038/nature01075 · DOI · Paper page
  40. Watanabe H, 2008, Cancer Cell Int, 8, 15, 10.1186/1475-2867-8-15 · DOI
  41. Weikert S, 2005, Int J Mol Med, 16, 349
  42. Orzan F, 2011, Neuropathol Appl Neurobiol, 37, 381, 10.1111/j.1365-2990.2010.01132.x · DOI
  43. Zhang R, 2012, Oncol Rep, 28, 2278, 10.3892/or.2012.2033 · DOI
  44. Smits M, 2010, Oncotarget, 1, 710, 10.18632/oncotarget.205 · DOI
  45. Crea F, 2010, Mol Cancer, 9, 265, 10.1186/1476-4598-9-265 · DOI · Paper page
  46. Ott M, 2012, PLoS One, 7, e47663, 10.1371/journal.pone.0047663 · DOI
  47. Wu Z, 2013, J Neurol Sci, 335, 191, 10.1016/j.jns.2013.09.030 · DOI
  48. Abdouh M, 2009, J Neurosci, 29, 8884, 10.1523/JNEUROSCI.0968-09.2009 · DOI
  49. Chan KM, 2013, Genes Dev, 27, 985, 10.1101/gad.217778.113 · DOI · Paper page
  50. Suva ML, 2009, Cancer Res, 69, 9211, 10.1158/0008-5472.CAN-09-1622 · DOI
  51. Kim E, 2013, Cancer Cell, 23, 839, 10.1016/j.ccr.2013.04.008 · DOI
  52. Weng YL, 2013, Neurotherapeutics, 10, 556, 10.1007/s13311-013-0223-4 · DOI
  53. Rottach A, 2009, J Cell Biochem, 108, 43, 10.1002/jcb.22253 · DOI
  54. Zhao YE, 2012, Parasitol Res, 110, 2395, 10.1007/s00436-011-2778-5 · DOI
  55. Brenner C, 2006, Curr Top Microbiol Immunol, 301, 45
  56. Turek-Plewa J, 2005, Cell Mol Biol Lett, 10, 631
  57. Roloff TC, 2003, BMC Genomics, 4, 1, 10.1186/1471-2164-4-1 · DOI
  58. Kimura H, 2003, J Biol Chem, 278, 4806, 10.1074/jbc.M209923200 · DOI
  59. Cimmino L, 2011, Cell Stem Cell, 9, 193, 10.1016/j.stem.2011.08.007 · DOI
  60. Frauer C, 2011, PLoS One, 6, e16627, 10.1371/journal.pone.0016627 · DOI
  61. Iyer L M, 2009, Cell Cycle, 8, 1698, 10.4161/cc.8.11.8580 · DOI
  62. Wu H, 2011, Nature, 473, 389, 10.1038/nature09934 · DOI · Paper page
  63. Freudenberg JM, 2012, Nucleic Acids Res, 40, 3364, 10.1093/nar/gkr1253 · DOI
  64. Rauch T, 2007, Proc Natl Acad Sci USA, 104, 5527, 10.1073/pnas.0701059104 · DOI
  65. 10.1038/nature04431 · DOI · Paper page
  66. Kreth S, 2011, PLoS One, 6, e17156, 10.1371/journal.pone.0017156 · DOI
  67. 10.1053/j.gastro.2009.10.002 · DOI · Paper page
  68. Pancione M, 2010, PLoS One, 5, e14229, 10.1371/journal.pone.0014229 · DOI
  69. Cartron PF, 2013, Genes Cancer, 4, 235, 10.1177/1947601913489020 · DOI
  70. Filipowicz W, 2005, Curr Opin Struct Biol, 15, 331, 10.1016/j.sbi.2005.05.006 · DOI
  71. 10.1038/nrg1379 · DOI · Paper page
  72. 10.1093/nar/gkq1027 · DOI · Paper page
  73. Krol J, 2010, Nat Rev Genet, 11, 597, 10.1038/nrg2843 · DOI · Paper page
  74. Sontheimer EJ, 2005, Cell, 122, 9, 10.1016/j.cell.2005.06.030 · DOI
  75. Hong L, 2013, Curr Drug Targets, 14, 1118, 10.2174/13894501113149990183 · DOI
  76. Pencheva N, 2013, Nat Cell Biol, 15, 546, 10.1038/ncb2769 · DOI
  77. Yates LA, 2013, Cell, 153, 516, 10.1016/j.cell.2013.04.003 · DOI
  78. Xiaoping L, 2013, Cell Death Dis, 4, e675, 10.1038/cddis.2013.197 · DOI
  79. Guo P, 2013, Oncol Rep, 30, 870, 10.3892/or.2013.2526 · DOI
  80. Rao ZY, 2010, Carcinogenesis, 31, 1576, 10.1093/carcin/bgq150 · DOI
  81. Ren G, 2012, Cancer Res, 72, 3091, 10.1158/0008-5472.CAN-11-3546 · DOI
  82. Qiu S, 2013, Biochim Biophys Acta, 1832, 1697, 10.1016/j.bbadis.2013.05.015 · DOI · Paper page
  83. Lee ST, 2011, J Neurooncol, 102, 19, 10.1007/s11060-010-0286-6 · DOI
  84. Kong D, 2012, PLoS One, 7, e33729, 10.1371/journal.pone.0033729 · DOI
  85. Chen Z, 2013, Biomed Res Int, 2013, 695179
  86. 10.1186/1476-4598-11-51 · DOI
  87. An L, 2013, PLoS One, 8, e69478, 10.1371/journal.pone.0069478 · DOI
  88. Lv Z, 2013, Mol Med Rep, 8, 345, 10.3892/mmr.2013.1561 · DOI
  89. Zheng F, 2012, Gut, 61, 278, 10.1136/gut.2011.239145 · DOI
  90. Li KK, 2013, Brain Pathol, 23, 426, 10.1111/bpa.12015 · DOI
  91. Luo C, 2013, J Invest Dermatol, 133, 768, 10.1038/jid.2012.357 · DOI
  92. Willemsen MH, 2011, J Med Genet, 48, 810, 10.1136/jmedgenet-2011-100294 · DOI · Paper page
  93. Qian X, 2013, CNS Neurosci Ther, 19, 804, 10.1111/cns.12149 · DOI
  94. Lu J, 2011, Cancer Res, 71, 225, 10.1158/0008-5472.CAN-10-1850 · DOI

Cited by

Sorted by citations

Metadata

Authors
Bian, E.-B., Li, J., He, X.-J., Zong, G., Jiang, T., Li, J., & Zhao, B.
Venue
Expert Opinion on Therapeutic Targets
Publisher
Informa UK Limited
Published
2014-07-21
Volume
18
Issue
10
Pages
1197-1206
ISSN
  • 1472-8222
  • 1744-7631
DOI
10.1517/14728222.2014.941807
Cited by
12
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review